Clearside Biomedical, Inc.
CLSDNASDAQHealthcare
$0.41
+$0.00(+0.00%)
Market Cap$2145948
P/E Ratio—
52W High$17.1
52W Low$0.31
Clearside Biomedical, Inc.（CLSD）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · CLSD · 截至 2026-06-09
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $1.66M | $8.23M | $1.33M | $29.57M | $7.89M |
| Cost of Revenue | $0.15M | $0.35M | $0.20M | $0.00M | $0.00M |
| Gross Profit | $1.51M | $7.87M | $1.12M | $29.57M | $7.89M |
| Gross Margin %(computed) | 91.05% | 95.68% | 84.63% | 100.00% | 100.00% |
| Operating Expenses | |||||
| R&D Expenses | $18.59M | $20.85M | $19.63M | $18.54M | $15.07M |
| G&A Expenses | $11.81M | $11.87M | $11.77M | $11.66M | $10.76M |
| Total Operating Expenses | $30.40M | $32.72M | $31.40M | $30.20M | $25.83M |
| Operating Income | ($28.88M) | ($24.84M) | ($30.28M) | ($0.63M) | ($17.93M) |
| Operating Margin %(computed) | — | -302.02% | — | -2.12% | -227.20% |
| Interest Income | $1.46M | $1.72M | $0.67M | $0.00M | $0.34M |
| Interest Expense | $9.78M | $9.36M | $3.34M | $0.00M | $0.34M |
| Income Before Tax | ($34.35M) | ($32.48M) | ($32.95M) | $0.38M | ($18.21M) |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Income | ($34.35M) | ($32.48M) | ($32.95M) | $0.38M | ($18.21M) |
| Net Margin %(computed) | — | -394.91% | — | 1.27% | -230.68% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-7.05 | $-7.95 | $-8.25 | $0.10 | $-5.85 |
| Wtd Avg Shares | 4.92M | 4.12M | 4.01M | 3.90M | 3.10M |
| EBITDA | ($24.35M) | ($23.06M) | ($29.46M) | $0.55M | ($17.70M) |
| EBITDA Margin %(computed) | — | -280.31% | — | 1.87% | -224.16% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-09 · USD · M
深入了解Clearside Biomedical, Inc.
关于Clearside Biomedical, Inc.（CLSD）损益表
Clearside Biomedical, Inc.（CLSD）损益表数据来源于SEC Form 10-K及10-Q申报文件。2024财年，CLSD实现营收$0.00B，毛利润$0.00B（毛利率91.05%），净利润($0.03B)（净利率-2064.42%）。
常见问题
CLSD · 4 问Clearside Biomedical, Inc.（CLSD）2024财年营收为$0.00B，同比down79.8%。
CLSD revenueCLSD salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09